Variables | Total (n = 91) | Severe (30, 33.0%) | Mild (61, 67.0%) | P value |
---|---|---|---|---|
WBC (×10^9/L) | 0.127 | |||
<4 | 27/91 (29.7%) | 7/30 (23.3%) | 20/61 (32.8%) | |
4–10 | 53/91 (58.2%) | 18/30 (60.0%) | 35/61 (57.4%) | |
>10 | 11/91 (12.1%) | 5/30 (16.7%) | 6/61 (9.8%) | |
Neutrophil (×10^9/L) | 0.467 | |||
≤ 6.3 | 80/91 (87.9%) | 26/30 (86.7%) | 54/61 (88.5%) | |
>6.3 | 11/91 (12.1%) | 4/30 (13.3%) | 7/61 (11.5%) | |
Monocytes (×10^9/L) | 0.190 | |||
≤ 0.6 | 66/91 (72.5%) | 20/30 (66.7%) | 46/61 (75.4%) | |
>0.6 | 25/91 (27.5%) | 10/30 (33.3%) | 15/61 (24.6%) | |
Lymphocytes (×10^9/L) | 0.022 | |||
≤ 1.1 | 47/91 (51.6%) | 11/30 (36.7%) | 36/61 (59.0%) | |
>1.1 | 44/91 (48.4%) | 19/30 (63.3%) | 25/61 (41.0%) | |
CTnI (μg/L) | 0.277 | |||
≤ 0.01 | 85/88 (96.6%) | 28/30 (93.3%) | 57/58 (98.3%) | |
>0.01 | 3/88 (3.4%) | 2/30 (6.7%) | 1/58 (1.7%) | |
CK (U/L) | 0.018 | |||
≤ 190 | 77/91 (84.6%) | 22/30 (73.3%) | 55/61 (90.0%) | |
>190 | 14/91 (15.4%) | 8/30 (26.7%) | 6/61 (9.8%) | |
CK-MB (U/L) | 0.099 | |||
≤ 24 | 87/91 (95.6%) | 27/30 (90.0%) | 60/61 (98.4%) | |
>24 | 4/91 (4.4%) | 3/30 (10.0%) | 1/61 (1.6%) | |
ALT (U/L) | 0.112 | |||
≤ 50 | 81/91 (89.0%) | 25/30 (83.3%) | 56/61 (91.8%) | |
>50 | 10/91 (11.0%) | 5/30 (16.7%) | 5/61 (8.2%) | |
AST (U/L) | 0.124 | |||
≤ 40 | 73/91 (80.0%) | 22/30 (73.3%) | 51/61 (83.6%) | |
>40 | 18/91 (19.8%) | 8/30 (26.7%) | 10/61 (16.4%) | |
Cr (μmol/L) | 0.000 | |||
≤ 97 | 86/91 (94.5%) | 25/30 (83.3%) | 61/61 (100%) | |
>97 | 5/91 (5.5%) | 5/30 (16.7%) | 0/61 (0%) | |
UA (μmol/L) | 0.202 | |||
≤ 417 | 86/91 (94.5%) | 27/30 (90.0%) | 59/61 (96.7%) | |
>417 | 5/91 (5.5%) | 3/30 (10.0%) | 2/61 (3.3%) | |
PT (s) | 0.100 | |||
≤ 12.8 | 72/91 (79.1%) | 22/30 (73.3%) | 50/61 (82%) | |
>12.8 | 19/91 (20.9%) | 8/30 (26.7%) | 11/61 (18.0%) | |
APTT(s) | 0.202 | |||
≤ 36.5 s | 86/91 (94.5%) | 27/30 (90.0%) | 59/61 (96.7%) | |
>36.5 | 5/91 (5.5%) | 3/30 (10.0%) | 2/61 (3.3%) | |
D-Dimer (ng/ml) | 0.484 | |||
≤ 232 | 78/82 (95.1%) | 28/30 (93.3%) | 50/52 (96.2%) | |
>232 | 4/82 (4.9%) | 2/30 (6.7%) | 2/52 (3.8%) | |
IL-6 (ng/ml) | 0.485 | |||
≤ 7 | 73/91 (80.2%) | 24/30 (80.0%) | 49/61 (80.3%) | |
>7 | 18/91 (19.8%) | 6/30 (20.0%) | 12/61 (19.7%) | |
CRP (mg/ml) | 0.240 | |||
≤ 10 | 56/91 (61.5%) | 20/30 (66.7%) | 36/61 (59.0%) | |
>10 | 35/91 (38.5%) | 10/30 (33.3%) | 25/61 (41.0%) | |
PCT (ng/ml) | 0.106 | |||
≤ 0.5 | 85/89 (95.5%) | 27/30 (90.0%) | 58/59 (98.3%) | |
>0.5 | 4/89 (4.5%) | 3/30 (10.0%) | 1/59 (1.7%) |